BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8545124)

  • 1. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B.
    Frank R; Zhang J; Uchida H; Meyers S; Hiebert SW; Nimer SD
    Oncogene; 1995 Dec; 11(12):2667-74. PubMed ID: 8545124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AML1A and AML1B can transactivate the human IL-3 promoter.
    Uchida H; Zhang J; Nimer SD
    J Immunol; 1997 Mar; 158(5):2251-8. PubMed ID: 9036972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
    Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD
    Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.
    Balkhi MY; Christopeit M; Chen Y; Geletu M; Behre G
    Exp Hematol; 2008 Nov; 36(11):1449-60. PubMed ID: 18687517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
    Meyers S; Lenny N; Sun W; Hiebert SW
    Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of GM-CSF gene transcription by core-binding factor.
    Cockerill PN; Osborne CS; Bert AG; Grotto RJ
    Cell Growth Differ; 1996 Jul; 7(7):917-22. PubMed ID: 8809409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AML1/ETO fusion protein activates transcription of BCL-2.
    Klampfer L; Zhang J; Zelenetz AO; Uchida H; Nimer SD
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14059-64. PubMed ID: 8943060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
    Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of different transcripts of AML1 on the transactivation of M-CSF-R gene].
    Zhang Q; Wang M; Xing HY; Rao Q; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):641-4. PubMed ID: 16620545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.
    Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H
    Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional domains of the t(8;21) fusion protein, AML-1/ETO.
    Lenny N; Meyers S; Hiebert SW
    Oncogene; 1995 Nov; 11(9):1761-9. PubMed ID: 7478604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms.
    Tanaka T; Tanaka K; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Shibata Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():299-302. PubMed ID: 9209372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETS1 transactivates the human GM-CSF promoter in Jurkat T cells stimulated with PMA and ionomycin.
    Thomas RS; Tymms MJ; Seth A; Shannon MF; Kola I
    Oncogene; 1995 Nov; 11(10):2135-43. PubMed ID: 7478534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
    Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
    Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A distinct epigenetic signature at targets of a leukemia protein.
    Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
    BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation.
    Kitabayashi I; Yokoyama A; Shimizu K; Ohki M
    EMBO J; 1998 Jun; 17(11):2994-3004. PubMed ID: 9606182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemogenesis by the chromosomal translocations.
    Mitani K
    Leukemia; 1997 Apr; 11 Suppl 3():294-6. PubMed ID: 9209370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.